Organicell Regenerative Medicine, Inc. (OCEL)

Other OTC - Other OTC Delayed Price. Currency in USD

0.0171

-0.0006

(-3.65%)

At close: 03:34PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	0.0178
Open	0.0180
Bid	N/A x N/A
Ask	N/A x N/A
Day's Range	0.0171 - 0.0180
52 Week Range	0.0100 - 0.0540
Volume	193,983
Avg. Volume	1,126,006

Market Cap	25.316M
Beta (5Y Monthly)	5.79
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0050
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for OCEL

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

ORGANICELL REGENERATIVE MEDICIN
VIVO: What does Argus have to say about VIVO?MERIDIAN BIOSCIENCE INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
3 days agoArgus Research